Home > Back to Publisher > Report Information

OTC Healthcare in the Baltic states to 2011

Datamonitor
August 5, 2008
181 Pages - SKU: DFMN1872835

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Estonia, Latvia, Lithuania

Introduction

This databook is a detailed information resource covering all the key data points on OTC Healthcare in the Baltic states. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.

Scope

Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
Provides market value, volume, expenditure and consumption data by market, segment and subsegment
Includes company and brand share data by categories

Highlights

The market for OTC Healthcare in the Baltic states increased between 2001-2006, growing at an average annual rate of 6.8%.

The leading company in the market in 2006 was Pfizer Inc. The second-largest player was GlaxoSmithKline Plc with Grindeks in third place.

Reasons to Purchase

Discover the major quantitative trends affecting the OTC Healthcare markets
Understand consumers' consumption and expenditure patterns
Understand the future direction of the market with reliable historical data and full five year forecasting

Additional Information

Databooks are a detailed information resource covering all the key data points across all industry verticals. They provide data covering a particular market at country or regional level in comprehensive tabular and brief contextual format. The databook allows the user to study and analyze the data. This databook is comprised of an overview chapter covering the market as a whole, a chapter examining each category within the market, and a chapter containing socioeconomic analysis and data. It also includes a chapter detailing Datamonitor’s research methodology, and an appendix containing additional details.

Chapter 1 EXECUTIVE SUMMARY
: Summary Market Level - OTC Healthcare; Summary category level - Analgesics; Summary category level - Cough and Cold Preparations; Summary category level - Traditional Medicines; Summary category level - First Aid Kits; Summary category level - Indigestion Preparations; Summary category level - Vitamins and Minerals; Summary category level - Plasters & Bandages; Summary category level - Medicated Skin Products; Summary category level - Other OTC Healthcare Products; Summary category level - Topical OTC Medicines
Chapter 2 INTRODUCTION
: What is this report about?; How to use this report; Market Definition
Chapter 3 MARKET OVERVIEW
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 4 LEADING COMPANY PROFILES
: Pfizer Inc; GlaxoSmithKline
Chapter 5 CATEGORY ANALYSIS - ANALGESICS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 13 CATEGORY ANALYSIS OTHER OTC HEALTHCARE PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 15 COUNTRY COMPARISON
: Value; Market Share
Chapter 16 BALTIC STATES SOCIOECONOMIC PROFILE
: Country Overview; Key Facts; Political Overview; Baltic States Economic Overview
Chapter 17 RESEARCH METHODOLOGY
: Methodology overview; Secondary research; Market modelling; Primary research; Data finalisation; Ongoing research
Chapter 18 APPENDIX
: Future readings; How to contact experts in your industry
LIST OF FIGURES
: Figure 1: Baltic States OTC Healthcare value & value forecast, 2001-2011 (LVL m, nominal prices); Figure 2: Baltic States OTC Healthcare category growth comparison, by value, 2001-2011; Figure 3: Baltic States OTC Healthcare company share, by value, 2005-2006 (%); Figure 4: Baltic States Analgesics value & value forecast, 2001-2011 (LVL m, nominal prices); Figure 5: Baltic States Analgesics category growth comparison, by value, 2001-2011; Figure 6: Baltic States Analgesics company share, by value, 2005-2006 (%); Figure 7: Baltic States Cough and Cold Preparations value & value forecast, 2001-2011 (LVL m, nominal prices); Figure 8: Baltic States Cough and Cold Preparations category growth comparison, by value, 2001-2011; Figure 9: Baltic States Cough and Cold Preparations company share, by value, 2005-2006 (%); Figure 10: Baltic States Traditional Medicines value & value forecast, 2001-2011 (LVL m, nominal prices); Figure 11: Baltic States First Aid Kits value & value forecast, 2001-2011 (LVL m, nominal prices); Figure 12: Baltic States First Aid Kits company share, by value, 2005-2006 (%); Figure 13: Baltic States Indigestion Preparations value & value forecast, 2001-2011 (LVL m, nominal prices); Figure 14: Baltic States Indigestion Preparations category growth comparison, by value, 2001-2011; Figure 15: Baltic States Indigestion Preparations company share, by value, 2005-2006 (%); Figure 16: Baltic States Vitamins and Minerals value & value forecast, 2001-2011 (LVL m, nominal prices); Figure 17: Baltic States Vitamins and Minerals category growth comparison, by value, 2001-2011; Figure 18: Baltic States Vitamins and Minerals company share, by value, 2005-2006 (%); Figure 19: Baltic States Plasters & Bandages value & value forecast, 2001-2011 (LVL m, nominal prices); Figure 20: Baltic States Plasters & Bandages category growth comparison, by value, 2001-2011; Figure 21: Baltic States Plasters & Bandages company share, by value, 2005-2006 (%); Figure 22: Baltic States Medicated Skin Products value & value forecast, 2001-2011 (LVL m, nominal prices); Figure 23: Baltic States Medicated Skin Products category growth comparison, by value, 2001-2011; Figure 24: Baltic States Medicated Skin Products company share, by value, 2005-2006 (%); Figure 25: Baltic States Other OTC Healthcare Products value & value forecast, 2001-2011 (LVL m, nominal prices); Figure 26: Baltic States Other OTC Healthcare Products category growth comparison, by value, 2001-2011; Figure 27: Baltic States Other OTC Healthcare Products company share, by value, 2005-2006 (%); Figure 28: Baltic States Topical OTC Medicines value & value forecast, 2001-2011 (LVL m, nominal prices); Figure 29: Baltic States Topical OTC Medicines category growth comparison, by value, 2001-2011; Figure 30: Baltic States Topical OTC Medicines company share, by value, 2005-2006 (%); Figure 31: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries; Figure 32: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries); Figure 33: Map of Baltic States; Figure 34: Annual data review process
LIST OF TABLES
: Table 1: OTC Healthcare category definitions; Table 2: Baltic States OTC Healthcare value, 2001-2006 (LVL m, nominal prices); Table 3: Baltic States OTC Healthcare value forecast, 2006-2011 (LVL m, nominal prices); Table 4: Baltic States OTC Healthcare value, 2001-2006 (US$ m nominal prices); Table 5: Baltic States OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices); Table 6: Baltic States OTC Healthcare brand share, by value, 2005-2006 (%); Table 7: Baltic States OTC Healthcare value, by brand 2005-2006 (LVL m nominal prices); Table 8: Baltic States OTC Healthcare company share by value, 2005-2006 (%); Table 9: Baltic States OTC Healthcare value, by company, 2005-2006 (LVL m nominal prices); Table 10: Baltic States OTC Healthcare expenditure per capita, 2001-2006 (LVL, nominal prices); Table 11: Baltic States OTC Healthcare forecast expenditure per capita, 2006-2011 (LVL, nominal prices); Table 12: Baltic States OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices); Table 13: Baltic States OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 14: Pfizer Inc Key Facts; Table 15: GlaxoSmithKline Key Facts; Table 16: Baltic States Analgesics value, 2001-2006 (LVL m, nominal prices); Table 17: Baltic States Analgesics value forecast, 2006-2011 (LVL m, nominal prices); Table 18: Baltic States Analgesics value, 2001-2006 (US$ m nominal prices); Table 19: Baltic States Analgesics value forecast, 2006-2011 (US$ m nominal prices); Table 20: Baltic States Analgesics brand share, by value, 2005-2006 (%); Table 21: Baltic States Analgesics value, by brand 2005-2006 (LVL m nominal prices); Table 22: Baltic States Analgesics company share by value, 2005-2006 (%); Table 23: Baltic States Analgesics value, by company, 2005-2006 (LVL m nominal prices); Table 24: Baltic States Analgesics expenditure per capita, 2001-2006 (LVL, nominal prices); Table 25: Baltic States Analgesics forecast expenditure per capita, 2006-2011 (LVL, nominal prices); Table 26: Baltic States Analgesics expenditure per capita, 2001-2006 (US$ nominal prices); Table 27: Baltic States Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 28: Baltic States Cough and Cold Preparations value, 2001-2006 (LVL m, nominal prices); Table 29: Baltic States Cough and Cold Preparations value forecast, 2006-2011 (LVL m, nominal prices); Table 30: Baltic States Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices); Table 31: Baltic States Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices); Table 32: Baltic States Cough and Cold Preparations brand share, by value, 2005-2006 (%); Table 33: Baltic States Cough and Cold Preparations value, by brand 2005-2006 (LVL m nominal prices); Table 34: Baltic States Cough and Cold Preparations company share by value, 2005-2006 (%); Table 35: Baltic States Cough and Cold Preparations value, by company, 2005-2006 (LVL m nominal prices); Table 36: Baltic States Cough and Cold Preparations expenditure per capita, 2001-2006 (LVL, nominal prices); Table 37: Baltic States Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (LVL, nominal prices); Table 38: Baltic States Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices); Table 39: Baltic States Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 40: Baltic States Traditional Medicines value, 2001-2006 (LVL m, nominal prices); Table 41: Baltic States Traditional Medicines value forecast, 2006-2011 (LVL m, nominal prices); Table 42: Baltic States Traditional Medicines value, 2001-2006 (US$ m nominal prices); Table 43: Baltic States Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices); Table 44: Baltic States Traditional Medicines brand share, by value, 2005-2006 (%); Table 45: Baltic States Traditional Medicines value, by brand 2005-2006 (LVL m nominal prices); Table 46: Baltic States Traditional Medicines company share by value, 2005-2006 (%); Table 47: Baltic States Traditional Medicines value, by company, 2005-2006 (LVL m nominal prices); Table 48: Baltic States Traditional Medicines expenditure per capita, 2001-2006 (LVL, nominal prices); Table 49: Baltic States Traditional Medicines forecast expenditure per capita, 2006-2011 (LVL, nominal prices); Table 50: Baltic States Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices); Table 51: Baltic States Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 52: Baltic States First Aid Kits value, 2001-2006 (LVL m, nominal prices); Table 53: Baltic States First Aid Kits value forecast, 2006-2011 (LVL m, nominal prices); Table 54: Baltic States First Aid Kits value, 2001-2006 (US$ m nominal prices); Table 55: Baltic States First Aid Kits value forecast, 2006-2011 (US$ m nominal prices); Table 56: Baltic States First Aid Kits brand share, by value, 2005-2006 (%); Table 57: Baltic States First Aid Kits value, by brand 2005-2006 (LVL m nominal prices); Table 58: Baltic States First Aid Kits company share by value, 2005-2006 (%); Table 59: Baltic States First Aid Kits value, by company, 2005-2006 (LVL m nominal prices); Table 60: Baltic States First Aid Kits expenditure per capita, 2001-2006 (LVL, nominal prices); Table 61: Baltic States First Aid Kits forecast expenditure per capita, 2006-2011 (LVL, nominal prices); Table 62: Baltic States First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices); Table 63: Baltic States First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 64: Baltic States Indigestion Preparations value, 2001-2006 (LVL m, nominal prices); Table 65: Baltic States Indigestion Preparations value forecast, 2006-2011 (LVL m, nominal prices); Table 66: Baltic States Indigestion Preparations value, 2001-2006 (US$ m nominal prices); Table 67: Baltic States Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices); Table 68: Baltic States Indigestion Preparations brand share, by value, 2005-2006 (%); Table 69: Baltic States Indigestion Preparations value, by brand 2005-2006 (LVL m nominal prices); Table 70: Baltic States Indigestion Preparations company share by value, 2005-2006 (%); Table 71: Baltic States Indigestion Preparations value, by company, 2005-2006 (LVL m nominal prices); Table 72: Baltic States Indigestion Preparations expenditure per capita, 2001-2006 (LVL, nominal prices); Table 73: Baltic States Indigestion Preparations forecast expenditure per capita, 2006-2011 (LVL, nominal prices); Table 74: Baltic States Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices); Table 75: Baltic States Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 76: Baltic States Vitamins and Minerals value, 2001-2006 (LVL m, nominal prices); Table 77: Baltic States Vitamins and Minerals value forecast, 2006-2011 (LVL m, nominal prices); Table 78: Baltic States Vitamins and Minerals value, 2001-2006 (US$ m nominal prices); Table 79: Baltic States Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices); Table 80: Baltic States Vitamins and Minerals brand share, by value, 2005-2006 (%); Table 81: Baltic States Vitamins and Minerals value, by brand 2005-2006 (LVL m nominal prices); Table 82: Baltic States Vitamins and Minerals company share by value, 2005-2006 (%); Table 83: Baltic States Vitamins and Minerals value, by company, 2005-2006 (LVL m nominal prices); Table 84: Baltic States Vitamins and Minerals expenditure per capita, 2001-2006 (LVL, nominal prices); Table 85: Baltic States Vitamins and Minerals forecast expenditure per capita, 2006-2011 (LVL, nominal prices); Table 86: Baltic States Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices); Table 87: Baltic States Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 88: Baltic States Plasters & Bandages value, 2001-2006 (LVL m, nominal prices); Table 89: Baltic States Plasters & Bandages value forecast, 2006-2011 (LVL m, nominal prices); Table 90: Baltic States Plasters & Bandages value, 2001-2006 (US$ m nominal prices); Table 91: Baltic States Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices); Table 92: Baltic States Plasters & Bandages brand share, by value, 2005-2006 (%); Table 93: Baltic States Plasters & Bandages value, by brand 2005-2006 (LVL m nominal prices); Table 94: Baltic States Plasters & Bandages company share by value, 2005-2006 (%); Table 95: Baltic States Plasters & Bandages value, by company, 2005-2006 (LVL m nominal prices); Table 96: Baltic States Plasters & Bandages expenditure per capita, 2001-2006 (LVL, nominal prices); Table 97: Baltic States Plasters & Bandages forecast expenditure per capita, 2006-2011 (LVL, nominal prices); Table 98: Baltic States Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices); Table 99: Baltic States Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 100: Baltic States Medicated Skin Products value, 2001-2006 (LVL m, nominal prices); Table 101: Baltic States Medicated Skin Products value forecast, 2006-2011 (LVL m, nominal prices); Table 102: Baltic States Medicated Skin Products value, 2001-2006 (US$ m nominal prices); Table 103: Baltic States Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices); Table 104: Baltic States Medicated Skin Products brand share, by value, 2005-2006 (%); Table 105: Baltic States Medicated Skin Products value, by brand 2005-2006 (LVL m nominal prices); Table 106: Baltic States Medicated Skin Products company share by value, 2005-2006 (%); Table 107: Baltic States Medicated Skin Products value, by company, 2005-2006 (LVL m nominal prices); Table 108: Baltic States Medicated Skin Products expenditure per capita, 2001-2006 (LVL, nominal prices); Table 109: Baltic States Medicated Skin Products forecast expenditure per capita, 2006-2011 (LVL, nominal prices); Table 110: Baltic States Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices); Table 111: Baltic States Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 112: Baltic States Other OTC Healthcare Products value, 2001-2006 (LVL m, nominal prices); Table 113: Baltic States Other OTC Healthcare Products value forecast, 2006-2011 (LVL m, nominal prices); Table 114: Baltic States Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices); Table 115: Baltic States Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices); Table 116: Baltic States Other OTC Healthcare Products brand share, by value, 2005-2006 (%); Table 117: Baltic States Other OTC Healthcare Products value, by brand 2005-2006 (LVL m nominal prices); Table 118: Baltic States Other OTC Healthcare Products company share by value, 2005-2006 (%); Table 119: Baltic States Other OTC Healthcare Products value, by company, 2005-2006 (LVL m nominal prices); Table 120: Baltic States Other OTC Healthcare Products expenditure per capita, 2001-2006 (LVL, nominal prices); Table 121: Baltic States Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (LVL, nominal prices); Table 122: Baltic States Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices); Table 123: Baltic States Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 124: Baltic States Topical OTC Medicines value, 2001-2006 (LVL m, nominal prices); Table 125: Baltic States Topical OTC Medicines value forecast, 2006-2011 (LVL m, nominal prices); Table 126: Baltic States Topical OTC Medicines value, 2001-2006 (US$ m nominal prices); Table 127: Baltic States Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices); Table 128: Baltic States Topical OTC Medicines brand share, by value, 2005-2006 (%); Table 129: Baltic States Topical OTC Medicines value, by brand 2005-2006 (LVL m nominal prices); Table 130: Baltic States Topical OTC Medicines company share by value, 2005-2006 (%); Table 131: Baltic States Topical OTC Medicines value, by company, 2005-2006 (LVL m nominal prices); Table 132: Baltic States Topical OTC Medicines expenditure per capita, 2001-2006 (LVL, nominal prices); Table 133: Baltic States Topical OTC Medicines forecast expenditure per capita, 2006-2011 (LVL, nominal prices); Table 134: Baltic States Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices); Table 135: Baltic States Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 136: Global OTC Healthcare market value, 2006; Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries; Table 138: Leading players - Top 5 countries; Table 139: Baltic States Key Facts

More Lithuania Over-the-Counter Drugs Reports

Medicated Skin Care in Lithuania by Euromonitor International
Medicated skin care showed signs of stabilising in 2011. Current retail value sales fell by just 1% in 2011, mainly due to the fact that ...

Herbal/Traditional Products in Lithuania by Euromonitor International
Consumers continued to seek herbal and traditional products in 2011 in line with the general trend towards consumption of more natural and organic goods. However, ...

Ear Care in Lithuania by Euromonitor International
The frugal habits of consumers had a negative impact on the performance of ear care products in Lithuania in 2011. Despite stable demand, price sensitive ...

Digestive Remedies in Lithuania by Euromonitor International
The prolonged economic downturn appears to have had little impact on the dietary habits of Lithuanians. Whilst the area did record a slight decline in ...

Cough, Cold and Allergy (Hay Fever) Remedies in Lithuania by Euromonitor International
The expected recovery of cough, cold and allergy (hay fever) sales did not occur in 2011. Consumers were unwilling to part with their money and ...

See all reports like this >>

More Lithuania Reports

D&B Country RiskLine Report: Lithuania by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: Lithuania by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

The Economic Competitiveness of Lithuania: Financials Returns, Labor Productivity and International Gaps by Icon Group International, Inc.
Is Lithuania competitive? With the globalization of markets, the increased mobility of corporate assets, and the need for productive human resources, this question has ...

World Markets Report: Lithuania by DRI-WEFA
This report (released semi-annually) covers all major economic and political issues for Lithuania, and how they affect the ten-year economic forecast. An executive summary ...

See all reports like this >>

OTC Healthcare in the Baltic states to 2011

Share this report

Other tasks

Research Assistance

Related Markets

Over-the-Counter Drugs Reports

Free Alert Me service